Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via Genetically Engineered Lipid‐Tagged Antibody Fragments
Advanced Materials · 2025-07 · 37 (27)
DOI: 10.1002/adma.202503060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 21.04.2025. Verfasst von Helong Kang und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, 300071, China. Hauptthemen laut MEDLINE: Immunotherapy, Single-Chain Antibodies, Nanoparticles, T-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
T cell engagers, which bind tumor‐associated antigens and T cell specific molecules, represent a promising class of immunotherapies for enhancing targeted immune responses. Here, a “plug‐and‐display” platform is introduced for engineering T cell nanoengagers by anchoring antibody fragments into lipid‐based nanoparticles. This approach utilizes a genetically engineered lipoprotein fused with single‐chain variable fragments (scFv) and nanobodies, which spontaneously integrate into lipid bilayer of the nanoparticles, achieving a high surface density of at least 0.102 scFv nm −2 (≈3200 scFv per particle). Modular bi‐specific (Lipo‐BiTE) and tri‐specific (Lipo‐TriTE) immunoliposomes are designed to enhance anti‐tumor T cell immune responses. The Lipo‐BiTE, integrating anti‐CD3 and anti‐HER2 scFv at an optimized surface density of 1.28 × 10 −3 scFv nm −2 , exhibits enhanced CD8 + T cell‐mediated cytotoxicity in HER2‐positive tumor models by simultaneously engaging tumor cells and T cells. Incorporating anti‐PD‐L1 nanobodies to create Lipo‐TriTE further addresses T cell exhaustion. This modular platform provides a robust foundation for designing immune cell engagers, with broad applications in targeted immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin, 300071, China.
- Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, 300071, China.
- Key Laboratory of Hebei Province for Molecular Biophysic Institute of Biophysics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, 300401, China.
ORCID-Profile: Xinglu Huang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Kang, H., Li, Y., Sun, F., Li, F., Zhu, M., Zhou, Z., Wu, J., Wang, K., Kutilike, B., Miao, Z., Xu, Y., Liu, R., Ding, D., Zhang, H., Huang, X., & Zhuang, J. (2025). Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via Genetically Engineered Lipid‐Tagged Antibody Fragments. Advanced Materials, 37(27). https://doi.org/10.1002/adma.202503060
Vancouver
Kang H, Li Y, Sun F, Li F, Zhu M, Zhou Z, et al. Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via Genetically Engineered Lipid‐Tagged Antibody Fragments. Advanced Materials. 2025;37(27). doi:10.1002/adma.202503060
BibTeX
@article{Kang2025,
author = {Kang, Helong and Li, Yuanke and Sun, Fude and Li, Fan and Zhu, Mingsheng and Zhou, Zheng and Wu, Jin and Wang, Keyu and Kutilike, Buayishamu and Miao, Zhizhao and Xu, Yanqin and Liu, Ruming and Ding, Dan and Zhang, Hongkai and Huang, Xinglu and Zhuang, Jie},
title = {Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via Genetically Engineered Lipid‐Tagged Antibody Fragments},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {27},
doi = {10.1002/adma.202503060}
}
EUVIMED